HomeHealthThe epidemiology of Parkinson's illness

The epidemiology of Parkinson’s illness

  • 1.

    The makes use of of ‘makes use of of epidemiology’.

    Int J Epidemiol. 2001; 30: 1146-1155

  • 2.
    • Pringsheim T
    • Jette N
    • Frolkis A
    • Steeves TD

    The prevalence of Parkinson’s illness: a scientific evaluation and meta-analysis.

    Mov Disord. 2014; 29: 1583-1590

  • 3.
    • Dorsey ER
    • Constantinescu R
    • Thompson JP
    • et al.

    Projected variety of folks with Parkinson illness in probably the most populous nations, 2005 by means of 2030.

    Neurology. 2007; 68: 384-386

  • 4.
    • Berg D
    • Postuma RB
    • Bloem B
    • et al.

    Time to redefine PD? Introductory assertion of the MDS Activity Drive on the definition of Parkinson’s illness.

    Mov Disord. 2014; 29: 454-462

  • 5.

    Parkinson illness in 2015: evolving primary, pathological and medical ideas in PD.

    Nat Rev Neurol. 2016; 12: 65-66

  • 6.
    • Siderowf A
    • Concha-Marambio L
    • Lafontant DE
    • et al.

    Evaluation of heterogeneity amongst members within the Parkinson’s Development Markers Initiative cohort utilizing α-synuclein seed amplification: a cross-sectional research.

    Lancet Neurol. 2023; 22: 407-417

  • 7.
    • Chahine LM
    • Service provider Okay
    • Siderowf A
    • et al.

    Proposal for a biologic staging system of Parkinson’s illness.

    J Parkinsons Dis. 2023; 13: 297-309

  • 8.
    • Lange LM
    • Gonzalez-Latapi P
    • Rajalingam R
    • et al.

    Nomenclature of genetic motion issues: suggestions of the Worldwide Parkinson and Motion Dysfunction Society activity drive – an replace.

    Mov Disord. 2022; 37: 905-935

  • 9.
    • Anheim M
    • Elbaz A
    • Lesage S
    • et al.

    Penetrance of Parkinson illness in glucocerebrosidase gene mutation carriers.

    Neurology. 2012; 78: 417-420

  • 10.
    • Hughes AJ
    • Daniel SE
    • Kilford L
    • Lees AJ

    Accuracy of medical prognosis of idiopathic Parkinson’s illness: a clinico-pathological research of 100 instances.

    J Neurol Neurosurg Psychiatry. 1992; 55: 181-184

  • 11.
    • Postuma RB
    • Berg D
    • Stern M
    • et al.

    MDS medical diagnostic standards for Parkinson’s illness.

    Mov Disord. 2015; 30: 1591-1601

  • 12.
    • Dickson DW
    • Braak H
    • Duda JE
    • et al.

    Neuropathological evaluation of Parkinson’s illness: refining the diagnostic standards.

    Lancet Neurol. 2009; 8: 1150-1157

  • 13.
    • Postuma RB
    • Poewe W
    • Litvan I
    • et al.

    Validation of the MDS medical diagnostic standards for Parkinson’s illness.

    Mov Disord. 2018; 33: 1601-1608

  • 14.
    • Berg D
    • Postuma RB
    • Adler CH
    • et al.

    MDS analysis standards for prodromal Parkinson’s illness.

    Mov Disord. 2015; 30: 1600-1611

  • 15.
    • Marini Okay
    • Seppi Okay
    • Tschiderer L
    • et al.

    Software of the up to date Motion Dysfunction Society standards for prodromal Parkinson’s illness to a population-based 10-year research.

    Mov Disord. 2021; 36: 1464-1466

  • 16.
    • Pilotto A
    • Heinzel S
    • Suenkel U
    • et al.

    Software of the Motion Dysfunction Society prodromal Parkinson’s illness analysis standards in 2 impartial potential cohorts.

    Mov Disord. 2017; 32: 1025-1034

  • 17.
    • Rocca WA
    • Yawn BP
    • St Sauver JL
    • Grossardt BR
    • Melton LJ third

    Historical past of the Rochester Epidemiology Challenge: half a century of medical data linkage in a US inhabitants.

    Mayo Clin Proc. 2012; 87: 1202-1213

  • 18.
    • Petersen BJ
    • Rocca WA
    • Bower JH
    • Savica R
    • Mielke MM

    Figuring out incident Parkinson’s illness utilizing administrative diagnostic codes: a validation research.

    Clin Park Relat Disord. 2020; 3: 100061

  • 19.
    • Jacobs BM
    • Belete D
    • Bestwick J
    • et al.

    Parkinson’s illness determinants, prediction and gene-environment interactions within the UK Biobank.

    J Neurol Neurosurg Psychiatry. 2020; 91: 1046-1054

  • 20.
    • Dorsey ER
    • Sherer T
    • Okun MS
    • Bloem BR

    The rising proof of the Parkinson pandemic.

    J Parkinsons Dis. 2018; 8: S3-S8

  • 21.
    • Dorsey ER
    • Elbaz A
    • Nichols E
    • et al.

    International, regional, and nationwide burden of Parkinson’s illness, 1990–2016: a scientific evaluation for the International Burden of Illness Examine 2016.

    Lancet Neurol. 2018; 17: 939-953

  • 22.
    • Tunstall-Pedoe H
    • Kuulasmaa Okay
    • Mähönen M
    • Tolonen H
    • Ruokokoski E
    • Amouyel P

    Contribution of developments in survival and coronary-event charges to modifications in coronary coronary heart illness mortality: 10-year outcomes from 37 WHO MONICA mission populations. Monitoring developments and determinants in heart problems.

    Lancet. 1999; 353: 1547-1557

  • 23.
    • Akushevich I
    • Kravchenko J
    • Ukraintseva S
    • Arbeev Okay
    • Yashin AI

    Time developments of incidence of age-associated ailments within the US aged inhabitants: Medicare-based evaluation.

    Age Ageing. 2013; 42: 494-500

  • 24.
    • Horsfall L
    • Petersen I
    • Walters Okay
    • Schrag A

    Time developments in incidence of Parkinson’s illness prognosis in UK main care.

    J Neurol. 2013; 260: 1351-1357

  • 25.
    • Darweesh SK
    • Koudstaal PJ
    • Stricker BH
    • Hofman A
    • Ikram MA

    Developments within the incidence of Parkinson illness within the basic inhabitants: the Rotterdam Examine.

    Am J Epidemiol. 2016; 183: 1018-1026

  • 26.
    • Savica R
    • Grossardt BR
    • Bower JH
    • Ahlskog JE
    • Rocca WA

    Time developments within the incidence of Parkinson illness.

    JAMA Neurol. 2016; 73: 981-989

  • 27.
    • Canonico M
    • Artaud F
    • Degaey I
    • et al.

    Incidence of Parkinson’s illness in French girls from the E3N cohort research over 27 years of follow-up.

    Eur J Epidemiol. 2022; 37: 513-523

  • 28.

    International developments within the incidence, prevalence, and years lived with incapacity of Parkinson’s illness in 204 international locations/territories from 1990 to 2019.

    Entrance Public Well being. 2021; 9: 776847

  • 29.
    • Cerdeña JP
    • Grubbs V
    • Non AL

    Racialising genetic danger: assumptions, realities, and suggestions.

    Lancet. 2022; 400: 2147-2154

  • 30.
    • Wright Willis A
    • Evanoff BA
    • Lian M
    • Criswell SR
    • Racette BA

    Geographic and ethnic variation in Parkinson illness: a population-based research of US Medicare beneficiaries.

    Neuroepidemiology. 2010; 34: 143-151

  • 31.
    • de Rijk MC
    • Tzourio C
    • Breteler MM
    • et al.

    Prevalence of parkinsonism and Parkinson’s illness in Europe: the EUROPARKINSON collaborative research. European neighborhood concerted motion on the epidemiology of Parkinson’s illness.

    J Neurol Neurosurg Psychiatry. 1997; 62: 10-15

  • 32.
    • Kasten M
    • Chade A
    • Tanner CM

    Epidemiology of Parkinson’s illness.

    Handb Clin Neurol. 2007; 83: 129-151

  • 33.
    • Bower JH
    • Maraganore DM
    • McDonnell SK
    • Rocca WA

    Affect of strict, intermediate, and broad diagnostic standards on the age- and sex-specific incidence of Parkinson’s illness.

    Mov Disord. 2000; 15: 819-825

  • 34.
    • Alves G
    • Forsaa EB
    • Pedersen KF
    • Dreetz Gjerstad M
    • Larsen JP

    Epidemiology of Parkinson’s illness..

    J Neurol. 2008; 255: 18-32

  • 35.
    • Ascherio A
    • Schwarzschild MA

    The epidemiology of Parkinson’s illness: danger elements and prevention.

    Lancet Neurol. 2016; 15: 1257-1272

  • 36.
    • Llibre-Guerra JJ
    • Prina M
    • Sosa AL
    • et al.

    Prevalence of parkinsonism and Parkinson illness in city and rural populations from Latin America: a neighborhood primarily based research.

    Lancet Reg Well being Am. 2022; 7: 100136

  • 37.
    • Okubadejo NU
    • Bower JH
    • Rocca WA
    • Maraganore DM

    Parkinson’s illness in Africa: a scientific evaluation of epidemiologic and genetic research.

    Mov Disord. 2006; 21: 2150-2156

  • 38.
    • Mayeux R
    • Marder Okay
    • Cote LJ
    • et al.

    The frequency of idiopathic Parkinson’s illness by age, ethnic group, and intercourse in northern Manhattan, 1988-1993.

    Am J Epidemiol. 1995; 142: 820-827

  • 39.
    • Muangpaisan W
    • Hori H
    • Brayne C

    Systematic evaluation of the prevalence and incidence of Parkinson’s illness in Asia.

    J Epidemiol. 2009; 19: 281-293

  • 40.
    • Zhang ZX
    • Roman GC
    • Hong Z
    • et al.

    Parkinson’s illness in China: prevalence in Beijing, Xian, and Shanghai.

    Lancet. 2005; 365: 595-597

  • 41.
    • Barbosa MT
    • Caramelli P
    • Maia DP
    • et al.

    Parkinsonism and Parkinson’s illness within the aged: a community-based survey in Brazil (the Bambuí research).

    Mov Disord. 2006; 21: 800-808

  • 42.
    • Nicoletti A
    • Sofia V
    • Bartoloni A
    • et al.

    Prevalence of Parkinson’s illness: a door-to-door survey in rural Bolivia.

    Parkinsonism Relat Disord. 2003; 10: 19-21

  • 43.
    • Melcon MO
    • Anderson DW
    • Vergara RH
    • Rocca WA

    Prevalence of Parkinson’s illness in Junín, Buenos Aires Province, Argentina.

    Mov Disord. 1997; 12: 197-205

  • 44.
    • Sánchez JL
    • Buriticá O
    • Pineda D
    • Uribe CS
    • Palacio LG

    Prevalence of Parkinson’s illness and parkinsonism in a Colombian inhabitants utilizing the capture-recapture methodology.

    Int J Neurosci. 2004; 114: 175-182

  • 45.
    • Chouza C
    • Ketzoian C
    • Caamaño JL
    • et al.

    Prevalence of Parkinson’s illness in a inhabitants of Uruguay. Preliminary outcomes.

    Adv Neurol. 1996; 69: 13-17

  • 46.
    • Giroud Benítez JL
    • Collado-Mesa F
    • Esteban EM

    Prevalence of Parkinson illness in an city space of the Ciudad de La Habana province, Cuba. Door-to-door inhabitants research..

    Neurología. 2000; 15 : 269-273

  • 47.
    • Correia Guedes L
    • Ferreira JJ
    • Rosa MM
    • Coelho M
    • Bonifati V
    • Sampaio C

    Worldwide frequency of G2019S LRRK2 mutation in Parkinson’s illness: a scientific evaluation.

    Parkinsonism Relat Disord. 2010; 16: 237-242

  • 48.
    • Sidransky E
    • Nalls MA
    • Aasly JO
    • et al.

    Multicenter evaluation of glucocerebrosidase mutations in Parkinson’s illness.

    N Engl J Med. 2009; 361: 1651-1661

  • 49.
    • Healy DG
    • Falchi M
    • O’Sullivan SS
    • et al.

    Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s illness: a case-control research.

    Lancet Neurol. 2008; 7: 583-590

  • 50.
    • Shu L
    • Zhang Y
    • Solar Q
    • Pan H
    • Tang B

    A complete evaluation of inhabitants variations in lrrk2 variant distribution in Parkinson’s illness.

    Entrance Ageing Neurosci. 2019; 11: 13

  • 51.
    • Dotchin C
    • Msuya O
    • Kissima J
    • et al.

    The prevalence of Parkinson’s illness in rural Tanzania.

    Mov Disord. 2008; 23: 1567-1672

  • 52.
    • Morens DM
    • Davis JW
    • Grandinetti A
    • Ross GW
    • Popper JS
    • White LR

    Epidemiologic observations on Parkinson’s illness: incidence and mortality in a potential research of middle-aged males.

    Neurology. 1996; 46: 1044-1050

  • 53.
    • Jendroska Okay
    • Olasode BJ
    • Daniel SE
    • et al.

    Incidental Lewy physique illness in black Africans.

    Lancet. 1994; 344: 882-883

  • 54.
    • Nag S
    • Barnes LL
    • Yu L
    • et al.

    Affiliation of Lewy our bodies with age-related medical traits in Black and White decedents.

    Neurology. 2021; 97: e825-e835

  • 55.
    • Van Den Eeden SK
    • Tanner CM
    • Bernstein AL
    • et al.

    Incidence of Parkinson’s illness: variation by age, gender, and race/ethnicity.

    Am J Epidemiol. 2003; 157: 1015-1022

  • 56.
    • Dahodwala N
    • Siderowf A
    • Xie M
    • Noll E
    • Stern M
    • Mandell DS

    Racial variations within the prognosis of Parkinson’s illness.

    Mov Disord. 2009; 24: 1200-1205

  • 57.
    • Troiano AR
    • Micheli FE
    • Alarcón F
    • Teive HA

    Motion issues in Latin America.

    Parkinsonism Relat Disord. 2006; 12: 125-138

  • 58.
    • Pitcher TL
    • Myall DJ
    • Pearson JF
    • et al.

    Parkinson’s illness throughout ethnicities: a nationwide research in New Zealand.

    Mov Disord. 2018; 33: 1440-1448

  • 59.
    • Dandona L
    • Dandona R
    • Kumar GA
    • et al.

    Nations inside a nation: variations in epidemiological transition throughout the states of India, 1990-2016 within the International Burden of Illness Examine.

    Lancet. 2017; 390: 2437-2460

  • 60.
    • Bennett DA
    • Beckett LA
    • Murray AM
    • et al.

    Prevalence of parkinsonian indicators and related mortality in a neighborhood inhabitants of older folks.

    N Engl J Med. 1996; 334: 71-76

  • 61.
    • Tansey MG
    • Wallings RL
    • Houser MC
    • Herrick MK
    • Keating CE
    • Joers V

    Irritation and immune dysfunction in Parkinson illness.

    Nat Rev Immunol. 2022; 22: 657-673

  • 62.
    • Wooten GF
    • Currie LJ
    • Bovbjerg VE
    • Lee JK
    • Patrie J

    Are males at higher danger for Parkinson’s illness than girls?.

    J Neurol Neurosurg Psychiatry. 2004; 75: 637-639

  • 63.
    • Chen W
    • Yan X
    • Lv H
    • Liu Y
    • He Z
    • Luo X

    Gender variations in prevalence of LRRK2-associated Parkinson illness: a meta-analysis of observational research.

    Neurosci Lett. 2020; 715: 134609

  • 64.
    • Nalls MA
    • Blauwendraat C
    • Vallerga CL
    • et al.

    Identification of novel danger loci, causal insights, and heritable danger for Parkinson’s illness: a meta-analysis of genome-wide affiliation research.

    Lancet Neurol. 2019; 18: 1091-1102

  • 65.
    • Anderson EL
    • Howe LD
    • Wade KH
    • et al.

    Training, intelligence and Alzheimer’s illness: proof from a multivariable two-sample mendelian randomization research.

    Int J Epidemiol. 2020; 49: 1163-1172

  • 66.
    • Lawlor DA
    • Tilling Okay
    • Davey Smith G

    Triangulation in aetiological epidemiology.

    Int J Epidemiol. 2016; 45: 1866-1886

  • 67.
    • Marras C
    • Canning CG
    • Goldman SM

    Surroundings, way of life, and Parkinson’s illness: implications for prevention within the subsequent decade.

    Mov Disord. 2019; 34: 801-811

  • 68.
    • Goldman SM
    • Marek Okay
    • Ottman R
    • et al.

    Concordance for Parkinson’s illness in twins: a 20-year replace.

    Ann Neurol. 2019; 85: 600-605

  • 69.
    • Lawton M
    • Tan MM
    • Ben-Shlomo Y
    • et al.

    Genetics of validated Parkinson’s illness subtypes within the Oxford Discovery and Monitoring Parkinson’s cohorts.

    J Neurol Neurosurg Psychiatry. 2022; 93: 952-959

  • 70.
    • Bellou V
    • Belbasis L
    • Tzoulaki I
    • Evangelou E
    • Ioannidis JP

    Environmental danger elements and Parkinson’s illness: an umbrella evaluation of meta-analyses.

    Parkinsonism Relat Disord. 2016; 23: 1-9

  • 71.
    • Ritz B
    • Ascherio A
    • Checkoway H
    • et al.

    Pooled evaluation of tobacco use and danger of Parkinson illness.

    Arch Neurol. 2007; 64: 990-997

  • 72.

    Appraising the causal function of smoking in a number of ailments: a scientific evaluation and meta-analysis of mendelian randomization research.

    EBioMedicine. 2022; 82: 104154

  • 73.
    • Ross GW
    • Abbott RD
    • Petrovitch H
    • et al.

    Affiliation of espresso and caffeine consumption with the danger of Parkinson illness.

    JAMA. 2000; 283: 2674-2679

  • 74.
    • Palacios N
    • Gao X
    • McCullough ML
    • et al.

    Caffeine and danger of Parkinson’s illness in a big cohort of women and men.

    Mov Disord. 2012; 27: 1276-1282

  • 75.
    • Park M
    • Ross GW
    • Petrovitch H
    • et al.

    Consumption of milk and calcium in midlife and the long run danger of Parkinson illness.

    Neurology. 2005; 64: 1047-1051

  • 76.
    • Kim IY
    • O’Reilly EJ
    • Hughes KC
    • et al.

    Integration of danger elements for Parkinson illness in 2 giant longitudinal cohorts.

    Neurology. 2018; 90: e1646-e1653

  • 77.
    • Gao X
    • Chen H
    • Schwarzschild MA
    • Ascherio A

    Use of ibuprofen and danger of Parkinson illness.

    Neurology. 2011; 76: 863-869

  • 78.
    • San Luciano M
    • Tanner CM
    • Meng C
    • et al.

    Nonsteroidal anti-inflammatory use and LRRK2 Parkinson’s illness penetrance.

    Mov Disord. 2020; 35: 1755-1764

  • 79.
    • Yang F
    • Trolle Lagerros Y
    • Bellocco R
    • et al.

    Bodily exercise and danger of Parkinson’s illness within the Swedish Nationwide March Cohort.

    Mind. 2015; 138: 269-275

  • 80.
    • Tanner CM
    • Goldman SM
    • Ross GW
    • Grate SJ

    The illness intersection of susceptibility and publicity: chemical exposures and neurodegenerative illness danger..

    Alzheimers Dement. 2014; 10: S213-S225

  • 81.

    Environmental toxins and Parkinson’s illness.

    Annu Rev Pharmacol Toxicol. 2014; 54: 141-164

  • 82.
    • Morris HR
    • Spillantini MG
    • Sue CM
    • Williams-Grey CH

    The pathogenesis of Parkinson’s illness.

    Lancet. 2024; 403: 293-304

  • 83.
    • Simon DK
    • Tanner CM
    • Brundin P

    Parkinson illness epidemiology, pathology, genetics, and pathophysiology.

    Clin Geriatr Med. 2020; 36: 1-12

  • 84.
    • Murata H
    • Barnhill LM
    • Bronstein JM

    Air air pollution and the danger of Parkinson’s illness: a evaluation.

    Mov Disord. 2022; 37: 894-904

  • 85.
    • Noyce AJ
    • Bestwick JP
    • Silveira-Moriyama L
    • et al.

    Meta-analysis of early nonmotor options and danger elements for Parkinson illness.

    Ann Neurol. 2012; 72: 893-901

  • 86.
    • Rugbjerg Okay
    • Ritz B
    • Korbo L
    • Martinussen N
    • Olsen JH

    Danger of Parkinson’s illness after hospital contact for head harm: inhabitants primarily based case-control research.

    BMJ. 2008; 337: a2494

  • 87.
    • Gardner RC
    • Byers AL
    • Barnes DE
    • Li Y
    • Boscardin J
    • Yaffe Okay

    Gentle TBI and danger of Parkinson illness: a Continual Results of Neurotrauma Consortium research.

    Neurology. 2018; 90: e1771-e1779

  • 88.
    • Goldman SM
    • Kamel F
    • Ross GW
    • et al.

    Head harm, α-synuclein Rep1, and Parkinson’s illness.

    Ann Neurol. 2012; 71: 40-48

  • 89.
    • Smeyne RJ
    • Noyce AJ
    • Byrne M
    • Savica R
    • Marras C

    An infection and danger of Parkinson’s illness.

    J Parkinsons Dis. 2021; 11: 31-43

  • 90.
    • Ross GW
    • Abbott RD
    • Petrovitch H
    • Tanner CM
    • White LR

    Pre-motor options of Parkinson’s illness: the Honolulu-Asia Ageing Examine expertise..

    Parkinsonism Relat Disord. 2012; 18: S199-S202

  • 91.
    • Ben-Shlomo Y
    • Cooper R
    • Kuh D

    The final 20 years of life course epidemiology, and its relevance for analysis on ageing.

    Int J Epidemiol. 2016; 45: 973-988

  • 92.
    • Miller DB
    • O’Callaghan JP

    Do early-life insults contribute to the late-life growth of Parkinson and Alzheimer ailments?.

    Metabolism. 2008; 57: S44-S49

  • 93.
    • Aisen PS
    • Jimenez-Maggiora GA
    • Rafii MS
    • Walter S
    • Raman R

    Early-stage Alzheimer illness: getting trial-ready.

    Nat Rev Neurol. 2022; 18: 389-399

  • 94.
    • Berg D
    • Crotty GF
    • Keavney JL
    • Schwarzschild MA
    • Simuni T
    • Tanner C

    Path to Parkinson illness prevention: conclusion and outlook..

    Neurology. 2022; 99: 76-83

  • 95.
    • de Vries NM
    • Darweesh SKL
    • Bloem BR

    Citius, Fortius, altius-understanding which elements drive train advantages in Parkinson illness.

    JAMA Neurol. 2021; 78: 1443-1445

  • 96.

    REM sleep habits dysfunction (RBD).

    Neurobiol Dis. 2020; 143: 104996

  • 97.
    • Fang X
    • Han D
    • Cheng Q
    • et al.

    Affiliation of ranges of bodily exercise with danger of Parkinson illness: a scientific evaluation and meta-analysis.

    JAMA Netw Open. 2018; 1: e182421

  • 98.
    • Bull FC
    • Al-Ansari SS
    • Biddle S
    • et al.

    World Well being Group 2020 tips on bodily exercise and sedentary behaviour.

    Br J Sports activities Med. 2020; 54: 1451-1462

  • 99.
    • Franco M
    • Bilal U
    • Orduñez P
    • et al.

    Inhabitants-wide weight reduction and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparability of secular developments.

    BMJ. 2013; 346: f1515

  • 100.
    • Schiess N
    • Cataldi R
    • Okun MS
    • et al.

    Six motion steps to deal with world disparities in Parkinson illness: a World Well being Group precedence.

    JAMA Neurol. 2022; 79: 929-936

  • Supply hyperlink


    Discover more from PressNewsAgency

    Subscribe to get the latest posts sent to your email.

    - Advertisment -